The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

MLA

Lozupone, Madia, et al. The Development of Peptide- and Oligonucleotide-Based Drugs to Prevent the Formation of Abnormal Tau in Tauopathies. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1414463441&authtype=sso&custid=ns315887.

APA

Lozupone, M., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Stallone, R., Altamura, M., Bellomo, A., Daniele, A., Solfrizzi, V., Panza, F., & Daniele, A. (ORCID:0000-0003-1641-5852). (2023). The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies.

Chicago

Lozupone, Madia, Vittorio Dibello, Rodolfo Sardone, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Ilaria Bortone, et al. 2023. “The Development of Peptide- and Oligonucleotide-Based Drugs to Prevent the Formation of Abnormal Tau in Tauopathies.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1414463441&authtype=sso&custid=ns315887.